FGF2 and sarcoma: After testing control cell lines, CSC from sarcoma samples were treated for 72 h with AA or DHA in conditions with/without bFGF to evaluate whether the absence of bFGF affects the cytotoxicity of these forms of ascorbate (Figure 3).